Trial intelligence / Profile preview

CLASS18: CLS with Carb Counting vs Meal Size Estimation

NCT04031599Completed

Sponsor
Montreal Clinical Research Institute
Start
Jul 2020
Primary completion
Nov 2021
Countries
1
01

Overview

Randomised, open-label trial in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Montreal Clinical Research Institute. Primary endpoints: Percentage of time of glucose levels spent between 3.9 and 10.0 mmol/L at 504 hours and Relative decrease in glucose levels during exercise compared to pre-breakfast levels at 4.5 hours. Started Jul 2020; status: completed.

02

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT04031599.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04031599.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call